Skip to main content
. 2025 Mar 24;21(7):1544–1555. doi: 10.1080/15548627.2025.2476872

Table 1.

Antibodies.

  Primary antibody Dilution   Secondary Dilution
Immunofluorescence
  MYH type IIa (DSHB, SC-71) 1:600   Alexa Fluor 488 IgG1 1:500
  MYH Type I (DSHB, BA-D5) 1:50   Alexa Fluor 555 IgM 1:500
  MYH Type IIb (DSHB, BF-F3) 1:100   Alexa Fluor 350 IgG2b 1:500
  PAX7 (DSHB, PAX7) 1:10   Alexa Fluor 488 IgG 1:500
 
LAM/laminin (Abcam, ab11575)
1:500
 
Alexa Fluor 568 IgG
1:500
 
Antibody
Dilution
 
Notes
Immunoblotting
  BNIP3L/Nix (Cell Signaling Technology [CST], 12396) 1:1000    
  BNIP3 (CST, 3769) 1:1000    
  Cre (CST 15,036) 1:1000    
  TUBB/β-tubulin (CST 86,298) 1:10000    
  SMAD2-SMAD3 (CST, 8685) 1:1000    
  Phoshp-SMAD2 (CST 18,338) 1:1000    
  MB/Myoglobin (CST 25,919) 1:10000   Reduced Protein (5 µg). Reduced secondary antibody (1:100,000)
  PPARGC1A/PGC1-α (Santa Cruz Biotechnology 13,067) 1:100    
  NFE2L2/NRF2 (CST 12,721) 1:1000    
  AIFM1/AIF1 (CST, 5318 1:1000    
  ATP2A/SERCA CST, 9580) 1:1000    
  SQSTM1/p62 (CST, 5114) 1:1000    
  LC3A (CST, 4599) 1:1000    
  Donkey anti-rabbit HRP
(Jackson Immunoresearch, 711-035-152)
1:10000    
  Donkey anti-mouse HRP
(Jackson Immunoresearch, 715-035-150)
1:10000    

DSHB, Developmental Studies Hybridoma Bank; all DSBH antibodies used are purchased as concentrated supernatant.